Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5551
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells ; day:7 ; month:4 ; year:2018 ; pages:1-5
Leukemia ; (7.4.2018), 1-5
- Urheber
-
Casado, Pedro
- Beteiligte Personen und Organisationen
-
Wilkes, Edmund H.
Miraki-Moud, Farideh
Hadi, Marym Mohammad
Rio-Machin, Ana
Rajeeve, Vinothini
Pike, Rebecca
Iqbal, Sameena
Marfa, Santiago
Lea, Nicholas
Best, Steven
Gribben, John
Fitzgibbon, Jude
Cutillas, Pedro
SpringerLink (Online service)
- DOI
-
10.1038/s41375-018-0032-1
- URN
-
urn:nbn:de:101:1-2018061122065134446786
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Casado, Pedro
- Wilkes, Edmund H.
- Miraki-Moud, Farideh
- Hadi, Marym Mohammad
- Rio-Machin, Ana
- Rajeeve, Vinothini
- Pike, Rebecca
- Iqbal, Sameena
- Marfa, Santiago
- Lea, Nicholas
- Best, Steven
- Gribben, John
- Fitzgibbon, Jude
- Cutillas, Pedro
- SpringerLink (Online service)
Ähnliche Objekte (12)
A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1
Protein kinase inhibitors for acute leukemia
Proteomic discovery of host kinase signaling in bacterial infections
Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma
A proteomic screen of Ty1 integrase partners identifies the protein kinase CK2 as a regulator of Ty1 retrotransposition
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA
Phosphoproteomic screening identifies physiological substrates of the CDKL 5 kinase
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia
Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse
Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1
Protein kinase inhibitors for acute leukemia
Proteomic discovery of host kinase signaling in bacterial infections
Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma
A proteomic screen of Ty1 integrase partners identifies the protein kinase CK2 as a regulator of Ty1 retrotransposition
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA
Phosphoproteomic screening identifies physiological substrates of the CDKL 5 kinase
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia
Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse
Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia
A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1
Protein kinase inhibitors for acute leukemia
Proteomic discovery of host kinase signaling in bacterial infections
Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma
A proteomic screen of Ty1 integrase partners identifies the protein kinase CK2 as a regulator of Ty1 retrotransposition
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA
Phosphoproteomic screening identifies physiological substrates of the CDKL 5 kinase
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia
Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse